100µg
ProteoGenix
Primary Antibodies
Monoclonal Antibody
Mammalian cells
MS
Carotuximab has been investigated for the treatment of Metastatic NSCLC, Recurrent Ovarian, Fallopian Tube, Primary Peritoneal Carcinoma, Advanced Soft Tissue Sarcoma, Hepatocellular Carcinoma, Glioblastoma, Glioblastoma Multiforme, Metastatic Breast Cancer and Advanced Angiosarcoma.
Reviews
There are no reviews yet.
Your email address will not be published. Required fields are marked *
In which application did you use the antibody? * WB ELISA Sandwich ELISA IF IHC IP FC other
Did it work in your application? * Yes No
Your review *
Name *
Email *
Save my name, email, and website in this browser for the next time I comment.
Got a question or need a quote? Message us and we’ll get back to you 48 hours or less.
First name
Last name
Email address
Lab / Company
Phone number
send